Download the list of NSQ samples for December 2021: The Central Drugs Standard Control Organisation (CDSCO) has declared 33 drug samples out of a total of 1385 drug samples tested as not of standard quality (NSQ) & 2 as misbranded during the month of December, 2021.

Out of the 1385 samples tested during the month, 1350 samples came out with standard quality, while 33 samples declared as not of standard quality (NSQ) & 2 as misbranded.

Click below link for detailed NSQ list December 2021

Drug-Alert-List-December-2021

Picture: Pixabay

None of the samples were identified as spurious and adulterated during the month. Every month, the drug regulator comes up with a list of drugs, medical devices and cosmetics that are declared not of standard quality / spurious / adulterated, or misbranded, every month.

During the month of Noember, 2021, the authorities tested 1102 samples, out of which 1080 samples were tested as of standard quality. The number of samples declared as not of standard quality was 22 and none as misbranded.

During the month of October, 2021, the authorities tested 1061 samples, out of which 1025 samples were tested as of standard quality. The number of samples declared as not of standard quality was 36 and none as misbranded.

During the month of September, 2021, the authorities tested 1227 samples, out of which 1184 samples were tested as of standard quality. The number of samples declared as not of standard quality was 42 and one as misbranded.

During the month of August, 2021, the authority has tested 1245 samples, out of which 1207 samples were tested as of standard quality. The number of samples declared as not of standard quality were 37 and one as misbranded.

During the month of July, 2021, the authority has tested 1028 samples, out of which 983 samples were tested as of standard quality. The number of samples declared as not of standard quality was 44

The test samples were drawn by the zonal and sub zonal offices of CDSCO, and tested in the drug testing laboratories in Kolkata, Mumbai, Hyderabad, Chandigarh, and Guwahati.

Month wise drug alerts

Drug alert: 22 out of 1102 samples declared as NSQ in November 2021

Drug alert: 36 out of 1061 samples declared as NSQ in October 2021

Drug alert: 42 out of 1227 samples declared as NSQ in September 2021

Drug alert: 38 out of 1245 samples declared as NSQ in August 2021

Drug alert: 44 out of 1028 samples declared as NSQ in July 2021

Drug alert: 39 out of 681 samples declared as NSQ in June 2021

Drug alert: 23 out of 648 samples declared as NSQ in May 2021

Drug alert: 23 out of 931 samples declared as NSQ in April 2021

Drug alert: 18 out of 1571 samples declared as NSQ in March 2021

Commercial Testing Laboratories

Govt Laboratories

List of Laboratory instruments

Latest Notifications: Testing Laboratories

Govt issues revised guidelines on use of drugs in Covid patients

USFDA gives approval to Strides Pharma for generic Tamiflu

DCGI gives nod to for Phase 3 Clinical Trial on drug...

Pharmaceutical Budget 2022: Expectations

NPPA to conduct study on Price Regulatory Policies in these 10...

Which medicine works best for Covid-19 treatment? WHO answers

FDA alerts Medical Officers to maintain healthy Oxygen status

IPC flags safety alert against Covid-19 drug Remdesivir

DCGI gives nod to for Phase 3 Clinical Trial on drug...

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/01/19/drug-alert-33-out-of-1385-samples-declared-as-nsq-in-december-2021/